NORTH CHICAGO (dpa-AFX) - Abbott Laboratories (ABT) Monday announced FDA
clearance for two new over-the-counter continuous glucose monitoring systems -
Lingo and Libre Rio.

Abbott said, these two systems are based on its FreeStyle Libre continuous
glucose monitoring technology.

Lingo is a consumer biowearable and is designed for general consumers who are
looking to improve their overall health and wellness, while Libre Rio is
designed for adults with Type 2 diabetes, who do not use insulin and manage
diabetes through lifestyle modifications.

The Lingo system combines a biosensor that is worn on the upper arm for 14 days.
Libre Rio is the first over-the-counter continuous glucose monitoring system
with a measurement range of 40-400 mg/dL.



Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX